Sunrest Lifescience Limited (NSEI: SUNREST)
Health Care · Pharmaceuticals · IN
Rs36.75
+3.52% today · -16.5% 1Y
Sunrest Lifescience Limited (NSEI: SUNREST) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.63M and employs 210 people.
Over the last twelve months the share price has lost 16.5%, trading between 29.55 and 54.00.
Tweenvest scores Sunrest Lifescience Limited across four factors: quality 64/100, value 81/100, growth 100/100. Its strongest factor is growth.
SUNREST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.63M
- Revenue (TTM)
- $7.55M
- P/E
- 3.83
- EPS
- 9.59
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- Rs54.00
- 52-week low
- Rs29.55
- Avg volume (3M)
- —
- Shares outstanding
- 4.29M
- Employees
- 210
- Next earnings
- —
About Sunrest Lifescience Limited
Sunrest Lifescience Ltd. is an India-based pharmaceutical company primarily engaged in the marketing and distribution of a diverse range of healthcare and personal care products within the domestic market. The company operates on an asset-light business model, outsourcing manufacturing to third-party producers and focusing its core competencies on product selection, marketing, and distribution. Its extensive product portfolio includes both over-the-counter (OTC) and prescription-based pharmaceutical formulations, encompassing tablets, capsules, ointments, injectables, syrups, and various other forms. Sunrest Lifescience caters to numerous therapeutic segments, including anti-bacterial, anti-diabetic, anti-fungal, anti-hypertensive, analgesic, nutritional, ayurvedic, and cosmetic products. The company primarily targets consumers in India, with significant market presence and a network of distributors and retailers across states such as Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, and Orissa.
- ISIN
- INE0PLZ01012
- Founded
- 2017
- Listed since
- Nov 20, 2023
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Artelo Biosciences, Inc.NasdaqCM: ARTL | $1.79M | $3.26 | -3.26% |
| Venmax Drugs and Pharmaceuticals LimitedBSE: 531015 | $1.72M | Rs14.40 | -0.69% |
| Zenith Healthcare LimitedBSE: 530665 | $1.72M | Rs3.10 | -1.59% |
| Captor Capital Corp.CNSX: CPTR | $1.64M | CA$0.67 | +15.52% |
| Desh Rakshak Aushdhalaya LimitedBSE: 531521 | $1.62M | Rs— | — |
| Norris Medicines LimitedBSE: 524414 | $1.58M | Rs15.25 | -6.44% |
| Shamrock Industrial Company LimitedBSE: 531240 | $1.54M | Rs27.25 | +4.97% |
| CanadaBis Capital Inc.TSXV: CANB | $1.53M | CA$— | — |
Figures last refreshed Oct 11, 2026.